Literature DB >> 2281432

Life threatening haemoptysis in cystic fibrosis: an alternative therapeutic approach.

D Bilton1, A K Webb, H Foster, P Mulvenna, M Dodd.   

Abstract

Desmopressin and vasopressin were used to control massive haemoptysis in a patient with cystic fibrosis. After bolus doses a continuous infusion of vasopressin was maintained for 36 hours and haemoptysis stopped.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2281432      PMCID： PMC462850          DOI： 10.1136/thx.45.12.975

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


  8 in total

1.  Hemoptysis: clinicians' perspectives.

Authors:  E F Haponik; R Chin
Journal:  Chest       Date:  1990-02       Impact factor: 9.410

Review 2.  Massive haemoptysis.

Authors:  D K Jones; R J Davis
Journal:  BMJ       Date:  1990-04-07

3.  Management of severe haemoptysis by bronchial artery embolisation in a patient with cystic fibrosis.

Authors:  A D King; D C Cumberland; S R Brennan
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

4.  Treatment and prognosis of massive hemoptysis in cystic fibrosis.

Authors:  R C Stern; R E Wood; T F Boat; L W Matthews; A S Tucker; C F Doershuk
Journal:  Am Rev Respir Dis       Date:  1978-05

5.  Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs.

Authors:  P M Mannucci; M Aberg; I M Nilsson; B Robertson
Journal:  Br J Haematol       Date:  1975-05       Impact factor: 6.998

6.  Bronchial artery embolization for severe hemoptysis in cystic fibrosis.

Authors:  N B Sweezey; K E Fellows
Journal:  Chest       Date:  1990-06       Impact factor: 9.410

7.  Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial.

Authors:  E W Salzman; M J Weinstein; R M Weintraub; J A Ware; R L Thurer; L Robertson; A Donovan; T Gaffney; V Bertele; J Troll
Journal:  N Engl J Med       Date:  1986-05-29       Impact factor: 91.245

8.  Cystic fibrosis in adolescents and adults.

Authors:  A R Penketh; A Wise; M B Mearns; M E Hodson; J C Batten
Journal:  Thorax       Date:  1987-07       Impact factor: 9.139
  8 in total
  1 in total

1.  [Emergencies in adult mucoviscidosis patients].

Authors:  C Smaczny; T Born; T O F Wagner
Journal:  Internist (Berl)       Date:  2012-05       Impact factor: 0.743
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.